adults

Dapagliflozin reduces risk of hospitalization in adults with chronic kidney disease

Leave a Comment / Medicine / By

December 05, 2022 2 minute read Source/Disclosures Disclosures: Schechter reports that the study was funded by AstraZeneca. He also reports receiving travel assistance from Novo Nordisk. Please see the study for relevant financial information from all other authors. ADD A SUBJECT TO EMAIL ALERTS Receive an email when new articles are published on Please provide …

Dapagliflozin reduces risk of hospitalization in adults with chronic kidney disease Read More »

1 in 8 adults experienced depression for the first time during the pandemic: Research

1 in 8 adults experienced depression for the first time during the pandemic: Research

Leave a Comment / Mental health / By

One in eight seniors in Canada, according to recent large-scale research that included more than 20,000 people, experienced their first episode of depression during the epidemic. The statistics were significantly worse for people who had previously struggled with depression. Almost half (45%) of this population reported suffering from depression in the fall of 2020. Analysis …

1 in 8 adults experienced depression for the first time during the pandemic: Research Read More »